ProCE Banner Activity

Drs Chloe Orkin and Babafemi Taiwo: Key HIV Studies From CROI 2024

Video

Hear from expert faculty as they present their insights on the most clinically relevant new data presented at CROI 2024, including discussions on long-acting ART, comorbidities and coinfections, and potential future treatment options for HIV.

Released: March 27, 2024

Expiration: March 26, 2025

Share

Faculty

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Disclosure

Primary Author

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Merck Sharpe & Dohme, ViiV.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Babafemi Taiwo, MBBS: consultant/advisor/speaker: Gilead, ViiV.